Although there was no significant change observed in body weight loss (supplementary Fig. 4A), or clinical disease (Supplementary Fig. 4B), PG-CAT treatment resulted in a significant improvement in airway obstruction (Supplementary Fig. 4C), and AHR (Supplementary Fig. 4D). This evidence concerns the gene AHR and Airway obstruction.